Cargando…

Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1

Glutaric acidemia type 1 (GA1) is a neurotoxic metabolic disorder due to glutaryl-CoA dehydrogenase (GCDH) deficiency. The high number of missense variants associated with the disease and their impact on GCDH activity suggest that disturbed protein conformation can affect the biochemical phenotype....

Descripción completa

Detalles Bibliográficos
Autores principales:	Barroso, Madalena, Gertzen, Marcus, Puchwein-Schwepcke, Alexandra F., Preisler, Heike, Sturm, Andreas, Reiss, Dunja D., Danecka, Marta K., Muntau, Ania C., Gersting, Søren W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487539/ https://www.ncbi.nlm.nih.gov/pubmed/37685964 http://dx.doi.org/10.3390/ijms241713158

Ejemplares similares

A novel mutation in the glutaryl‐CoA dehydrogenase gene (GCDH) in an Iranian patient affected with Glutaric acidemia type 1
por: Rayat, Sima, et al.
Publicado: (2021)

The Domain-Specific and Temperature-Dependent Protein Misfolding Phenotype of Variant Medium-Chain acyl-CoA Dehydrogenase
por: Jank, Johanna M., et al.
Publicado: (2014)

Interaction of Glutaric Aciduria Type 1-Related glutaryl-CoA Dehydrogenase with Mitochondrial Matrix Proteins
por: Schmiesing, Jessica, et al.
Publicado: (2014)

Increased glutarate production by blocking the glutaryl-CoA dehydrogenation pathway and a catabolic pathway involving l-2-hydroxyglutarate
por: Zhang, Manman, et al.
Publicado: (2018)

Glutaric Acidemia, Pathogenesis and Nutritional Therapy
por: Li, Qian, et al.
Publicado: (2021)

Orthopaedic manifestations of glutaric acidemia Type 1
por: Imerci, Ahmet, et al.
Publicado: (2020)

A Low-Excretor Biochemical Phenotype of Glutaric Aciduria Type I: Identification of Novel Mutations in the Glutaryl CoA Dehydrogenase Gene and Review of Literature from India
por: Shaik, Muntaj, et al.
Publicado: (2020)

Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening
por: Maier, Esther M., et al.
Publicado: (2009)

Probing conformational states of glutaryl-CoA dehydrogenase by fragment screening
por: Begley, Darren W., et al.
Publicado: (2011)

OR11-001 - Protein misfolding in mevalonate kinase deficiency
por: Stojanov, S, et al.
Publicado: (2013)

ProtTrans-Glutar: Incorporating Features From Pre-trained Transformer-Based Models for Predicting Glutarylation Sites
por: Indriani, Fatma, et al.
Publicado: (2022)

A new celll model of glutaric acidemia type I and the toxicity research
por: Zhang, Cai, et al.
Publicado: (2013)

Detection of glutaric acidemia type 1 in infants through tandem mass spectrometry
por: Babu, Ruby P., et al.
Publicado: (2015)

Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice
por: Bhatt, Dhaval P., et al.
Publicado: (2022)

Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1
por: Zayed, Hatem, et al.
Publicado: (2019)

The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease
por: Gomez, Sabas I, et al.
Publicado: (2014)

Inborn errors of metabolism and the human interactome: a systems medicine approach
por: Woidy, Mathias, et al.
Publicado: (2018)

Biochemical and molecular features of Chinese patients with glutaric acidemia type 1 detected through newborn screening
por: Lin, Yiming, et al.
Publicado: (2021)

Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors
por: Roy, Satyajeet, et al.
Publicado: (2017)

Targeted suppression of glutaryl-CoA dehydrogenase by lentivirus-mediated SHRNA and excessive intake of lysine induce the apoptosis of rat striatal neurons
por: Jinzhi, Gao, et al.
Publicado: (2013)

Neonatal Astrocyte Damage Is Sufficient to Trigger Progressive Striatal Degeneration in a Rat Model of Glutaric Acidemia-I
por: Olivera-Bravo, Silvia, et al.
Publicado: (2011)

Biochemical and molecular features of chinese patients with glutaric acidemia type 1 from Fujian Province, southeastern China
por: Zhou, Jinfu, et al.
Publicado: (2023)

Effects of Targeted Suppression of Glutaryl-CoA Dehydrogenase by Lentivirus-Mediated shRNA and Excessive Intake of Lysine on Apoptosis in Rat Striatal Neurons
por: Gao, Jinzhi, et al.
Publicado: (2013)

Prenatal Diagnosis of Glutaric Acidemia I Based on Amniotic Fluid Samples in 42 Families Using Genetic and Biochemical Approaches
por: Xiao, Bing, et al.
Publicado: (2020)

In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase
por: Azmi, Muhammad Bilal, et al.
Publicado: (2021)

Functions and Mechanisms of Lysine Glutarylation in Eukaryotes
por: Xie, Longxiang, et al.
Publicado: (2021)

The low excretor phenotype of glutaric acidemia type I is a source of false negative newborn screening results and challenging diagnoses
por: Guenzel, Adam J., et al.
Publicado: (2021)

The Endothelial Glycocalyx: Physiology and Pathology in Neonates, Infants and Children
por: Puchwein-Schwepcke, Alexandra, et al.
Publicado: (2021)

Preparation of Affinity Purified Antibodies against ε-Glutaryl-Lysine Residues in Proteins for Investigation of Glutarylated Proteins in Animal Tissues
por: Artiukhov, Artem V., et al.
Publicado: (2021)

Increased Glutamate Receptor and Transporter Expression in the Cerebral Cortex and Striatum of Gcdh (-/-) Mice: Possible Implications for the Neuropathology of Glutaric Acidemia Type I
por: Lagranha, Valeska Lizzi, et al.
Publicado: (2014)

Once in a Blue Moon, a Very Rare Coexistence of Glutaric Acidemia Type I and Mucopolysaccharidosis Type IIIB in a Patient
por: Alaei, Mohammad Reza, et al.
Publicado: (2020)

Formation of 3‐hydroxyglutaric acid in glutaric aciduria type I: in vitro participation of medium chain acyl‐CoA dehydrogenase
por: Peters, Verena, et al.
Publicado: (2019)

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies
por: Drouot, Laurent, et al.
Publicado: (2014)

A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family
por: Ou, Mingcai, et al.
Publicado: (2020)

Glutaric acidemia type II patient with thalassemia minor and novel electron transfer flavoprotein-A gene mutations: A case report and review of literature
por: Saral, Neslihan Yildirim, et al.
Publicado: (2018)

In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against Naegleria fowleri
por: Hahn, Hye Jee, et al.
Publicado: (2020)

Effects of Prematurity on the Cutaneous Microcirculatory Network in the First Weeks of Life
por: Puchwein-Schwepcke, Alexandra, et al.
Publicado: (2019)

Relief of CoA sequestration and restoration of mitochondrial function in a mouse model of propionic acidemia
por: Subramanian, Chitra, et al.
Publicado: (2022)

Specific CD4+ T Cell Responses to Ancestral SARS-CoV-2 in Children Increase With Age and Show Cross-Reactivity to Beta Variant
por: Paul, Kevin, et al.
Publicado: (2022)

Toxic response caused by a misfolding variant of the mitochondrial protein short-chain acyl-CoA dehydrogenase
por: Schmidt, Stinne P., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e488dnn6c9pokht6ojm1844krg